Trial of Linaclotide in Patients With Chronic Constipation
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to determine the efficacy and safety of linaclotide
administered to patients with chronic constipation (CC). The primary efficacy parameter is
the percentage of patients in each dosing group that meet the protocol definition for
Complete Spontaneous Bowel Movement (CSBM) Overall Responder.